Moderna, Inc.

Historical 13F Holders

Symbol
MRNA
CUSIP
60770K107
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 712 276 M $7.15 B
2025 Q2 746 302 M $8.33 B
2025 Q1 762 279 M $7.90 B
2024 Q4 834 277 M $11.5 B
2024 Q3 885 264 M $17.6 B
2024 Q2 1,058 269 M $31.9 B
2024 Q1 997 275 M $29.4 B
2023 Q4 981 269 M $26.8 B
2023 Q3 980 247 M $25.9 B
2023 Q2 1,047 248 M $30.2 B
2023 Q1 1,105 273 M $38.5 B
2022 Q4 1,169 263 M $47.5 B
2022 Q3 1,006 248 M $29.3 B
2022 Q2 1,128 245 M $34.9 B
2022 Q1 1,116 251 M $43.2 B
2021 Q4 1,207 250 M $63.4 B
2021 Q3 1,240 243 M $93.5 B
2021 Q2 993 229 M $53.9 B
2021 Q1 855 210 M $27.4 B
2020 Q4 804 201 M $21.1 B
2020 Q3 626 206 M $14.5 B
2020 Q2 542 220 M $14.1 B
2020 Q1 334 196 M $5.88 B
2019 Q4 177 177 M $3.45 B
2019 Q3 151 169 M $2.69 B
2019 Q2 161 144 M $2.10 B
2019 Q1 115 138 M $2.80 B
2018 Q4 83 134 M $2.02 B